SUDEEP PHARMA
Back to Balance Sheet
|
SUDEEP PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹8.91 Cr | ₹6.03 Cr | ₹5.62 Cr | ₹4.59 Cr | ₹4.44 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUDEEP PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹8.91 Cr |
| Mar2025 | ₹6.03 Cr |
| Mar2024 | ₹5.62 Cr |
| Mar2023 | ₹4.59 Cr |
| Mar2022 | ₹4.44 Cr |
How is Deferred Tax Assets / Liabilities of SUDEEP PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.91 Cr | 47.63 | |
| Mar2025 | ₹6.03 Cr | 7.40 | |
| Mar2024 | ₹5.62 Cr | 22.42 | |
| Mar2023 | ₹4.59 Cr | 3.26 | |
| Mar2022 | ₹4.44 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹12,553.4 Cr | -7.4% | -16% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -7.4% |
-16% |
|
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses